Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. NVDA
6. CRCL
7. V
8. HOOD
9. XOM
10. GE

Go back to Eli Lilly & Co. (LLY) Announces US FDA accepts supplemental New Drug Application for Jardiance® for children 10 years and older with type 2 diabetes
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1149.36 --0 (-0%)
Previous Close $1149.36    52 Week High $88.16 
Open $1149.36    52 Week Low $67.88 
Day High $1149.36    P/E 266.06 
Day Low $1149.36    EPS $4.32 
Volume 30,652